Skip to main content
SpringerLink
Log in

Metachronous colorectal cancer

  • Published:
Techniques in Coloproctology Aims and scope Submit manuscript

Abstract

Aim

In this study, we present our patients with metachronous colorectal cancer.

Patients and methods

In the period between 1990 and 2009, 670 patients with colorectal cancer were treated.

Results

Metachronous cancer was developed in 4 (0.6%) patients. The time interval between index and metachronous cancer was 28 months to 22 years (mean 146 months).

Conclusion

Metachronous colorectal cancer is a potential risk that proves the necessity of postoperative colonoscopic control of all patients with colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cali RL, Pitsch RM, Thomson AG et al (1993) Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 36:388–393

    Article  CAS  PubMed  Google Scholar 

  2. Miller BJ, Cohen JR (2003) Gastointestinal: synchronous and metachronous colorectal cancers. J Gastroenterol Hepatol 18:457

    Article  Google Scholar 

  3. Fukutomi Y, Moriwaki H, Nagase S et al (2002) Metachronous colon tumors: risk factors and rationale for the surveillance colonoscopy after initial polypestomy. J Cancer Res Clin Oncol 128:569–574

    Article  PubMed  Google Scholar 

  4. Nelson RL, Persky V, Turyk M (1999) Determination of factors responsible for the declining incidence of colorectal cancer. Dis Colon Rectum 42:741–752

    Article  CAS  PubMed  Google Scholar 

  5. Sonnenberg A, Delco F, Inadomi JM (2000) Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 133:573–584

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest related to the publication of this article.

Author information

Authors and Affiliations

  1. 4th Surgical Department, Aristotle University, Thessaloniki, Greece

    M. G. Pramateftakis, P. Hatzigianni, D. Kanellos, G. Vrakas, Th. Tsachalis, I. Mantzoros, I. Kanellos & C. Lazaridis

  2. Antheon 1, Panorama, 55236, Thessaloniki, Greece

    M. G. Pramateftakis

Authors
  1. M. G. Pramateftakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Hatzigianni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Kanellos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Vrakas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Th. Tsachalis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I. Mantzoros
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I. Kanellos
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. Lazaridis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. G. Pramateftakis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pramateftakis, M.G., Hatzigianni, P., Kanellos, D. et al. Metachronous colorectal cancer. Tech Coloproctol 14 (Suppl 1), 63–64 (2010). https://doi.org/10.1007/s10151-010-0623-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10151-010-0623-y

Keywords

Search

Navigation